Michael D Ezekowitz
Overview
Explore the profile of Michael D Ezekowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
186
Citations
21176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cappato R, Ezekowitz M, Hohnloser S, Meng I, Wosnitza M, Camm A
Europace
. 2021 Jun;
23(10):1539-1547.
PMID: 34128075
Aims: Using a pre-planned post hoc analysis of patients included in X-VeRT, we evaluated predictors of sinus rhythm at 6 weeks after planned cardioversion. Methods And Results: Receiver operating characteristic...
12.
Liu H, Ezekowitz M, Columbo M, Khan O, Martin J, Spahr J, et al.
J Interv Card Electrophysiol
. 2021 May;
63(2):345-356.
PMID: 34037911
Background: The coronavirus SARS-CoV-2 is highly contagious. Hydroxychloroquine (HCQ) has in vitro activity against SARS-CoV-2. The FDA authorized emergency use of HCQ against COVID-19. HCQ may have dose-related cardiotoxicity. This...
13.
Pol T, Hijazi Z, Lindback J, Alexander J, Bahit M, De Caterina R, et al.
Open Heart
. 2021 Mar;
8(1).
PMID: 33741689
Objectives: Growth differentiation factor 15 (GDF-15) is a biomarker independently associated with bleeding and death in anticoagulated patients with atrial fibrillation (AF). GDF-15 is also used as one component in...
14.
Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease
Benz A, Healey J, Chin A, Commerford P, Marsden T, Karthikeyan G, et al.
Cardiovasc Res
. 2021 Jan;
118(1):295-304.
PMID: 33386845
Aims: Patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), especially mitral stenosis, are assumed to be at high risk of stroke, irrespective of other factors. We aimed to...
15.
Hijazi Z, Wallentin L, Lindback J, Alexander J, Connolly S, Eikelboom J, et al.
J Am Heart Assoc
. 2020 Dec;
9(24):e018984.
PMID: 33292046
Background To explore the pathophysiological features of ischemic stroke in patients with atrial fibrillation (AF), we evaluated the association between 268 plasma proteins and subsequent ischemic stroke in 2 large...
16.
Wallentin L, Lindback J, Eriksson N, Hijazi Z, Eikelboom J, Ezekowitz M, et al.
Eur Heart J
. 2020 Sep;
41(41):4037-4046.
PMID: 32984892
Aims: The global COVID-19 pandemic is caused by the SARS-CoV-2 virus entering human cells using angiotensin-converting enzyme 2 (ACE2) as a cell surface receptor. ACE2 is shed to the circulation,...
17.
Hijazi Z, Oldgren J, Lindback J, Alexander J, Alings M, De Caterina R, et al.
JAMA Netw Open
. 2020 Sep;
3(9):e2015943.
PMID: 32936298
Importance: Most patients with atrial fibrillation (AF) and coronary artery disease have indications for preventing stroke with oral anticoagulation therapy and preventing myocardial infarction and stent thrombosis with platelet inhibition....
18.
Geurink K, Holmes D, Ezekowitz M, Pieper K, Fonarow G, Kowey P, et al.
Heart
. 2020 Jun;
107(8):642-649.
PMID: 32591363
Background: Cardioversion is common among patients with atrial fibrillation (AF). We hypothesised that novel oral anticoagulants (NOAC) used in clinical practice resulted in similar rates of stroke compared with vitamin...
19.
Aulin J, Hijazi Z, Siegbahn A, Andersson U, Alexander J, Connolly S, et al.
J Thromb Haemost
. 2020 Jun;
18(9):2287-2295.
PMID: 32510737
Background: The inflammatory biomarker interleukin-6 (IL-6) is associated with mortality in atrial fibrillation (AF). Objective: To investigate if repeated IL-6 measurements improve the prognostication for stroke or systemic embolism, major...
20.
Ali-Ahmed F, Pieper K, North R, Allen L, Chan P, Ezekowitz M, et al.
Eur Heart J Qual Care Clin Outcomes
. 2020 May;
6(4):263-272.
PMID: 32392287
Aims: To determine the extent of shared decision-making (SDM), during selection of oral anticoagulant (OAC) and rhythm control treatments, in patients with newly diagnosed atrial fibrillation (AF). Methods And Results:...